8.65

1.76% 0.15

Health Catalyst Inc (HCAT)

Overview News Price History Option Chain Financials Discussions Forecast

Health Catalyst Inc stock is traded at $8.65, with a volume of 462.81K. It is up +1.76% in the last 24 hours and up +12.92% over the past month. Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Previous Close:

$8.50

Open:

$8.52

24h Volume:

462.81K

Relative Volume:

0.97

Market Cap:

$519.94M

Revenue:

$299.48M

Net Income/Loss:

$-86.45M

P/E Ratio:

-3.2276

EPS:

-2.68

Net Cash Flow:

$-17.32M

1W Performance:

+17.53%

1M Performance:

+12.92%

6M Performance:

+28.53%

1Y Performance:

+16.58%

1-Day Range:

$8.52

$8.83

1-Week Range:

$7.31

$8.83

52-Week Range:

$5.42

$11.41

Health Catalyst Inc Stock (HCAT) Company Profile

Name

Health Catalyst Inc

Sector

Healthcare (1200)

Industry

Health Information Services (60)

Phone

801-708-6800

Address

10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN

Employee

1,300

Twitter

@HealthCatalyst

Next Earnings Date

2024-11-06

Latest SEC Filings

HCAT's Discussions on Twitter

Compare HCAT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCAT Health Catalyst Inc	8.65	519.94M	299.48M	-86.45M	-17.32M	-2.68
VEEV Veeva Systems Inc	226.76	36.93B	2.57B	615.26M	996.76M	3.32
SOLV Solventum Corp	72.48	12.43B	8.26B	66.00M	1.17B	0.00
TEM Tempus Ai Inc	62.98	10.01B	640.44M	-743.28M	-206.93M	0.00
DOCS Doximity Inc	53.39	9.94B	493.63M	160.55M	162.20M	0.55
HQY Healthequity Inc	102.47	8.91B	1.10B	105.67M	-197.98M	0.1475

Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-03-24	Initiated	Barclays	Overweight
Jan-03-24	Upgrade	Evercore ISI	In-line → Outperform
Dec-13-23	Upgrade	JP Morgan	Neutral → Overweight
Nov-13-23	Upgrade	Piper Sandler	Neutral → Overweight
Aug-01-23	Initiated	Cantor Fitzgerald	Overweight
May-10-23	Downgrade	Guggenheim	Buy → Neutral
May-10-23	Downgrade	Raymond James	Outperform → Mkt Perform
Apr-20-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-12-23	Initiated	Stephens	Equal-Weight
Apr-04-23	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Oct-31-22	Initiated	Wells Fargo	Equal Weight
Oct-25-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-13-22	Downgrade	Piper Sandler	Overweight → Neutral
Aug-05-22	Downgrade	JP Morgan	Overweight → Neutral
Aug-05-22	Downgrade	Stifel	Buy → Hold
Apr-14-22	Initiated	Guggenheim	Buy
Mar-17-22	Upgrade	Jefferies	Hold → Buy
Feb-11-22	Initiated	Goldman	Buy
Dec-02-21	Initiated	Jefferies	Hold
Oct-14-21	Initiated	BTIG Research	Buy
Apr-29-21	Resumed	JP Morgan	Overweight
Dec-08-20	Initiated	Berenberg	Buy
Jul-14-20	Initiated	Citigroup	Buy
Jun-18-20	Initiated	Stifel	Buy
Jun-15-20	Resumed	Evercore ISI	Outperform
May-15-20	Initiated	Guggenheim	Buy
Apr-21-20	Initiated	RBC Capital Mkts	Outperform
Apr-13-20	Initiated	SVB Leerink	Outperform
Apr-02-20	Initiated	Canaccord Genuity	Buy
Dec-20-19	Initiated	Raymond James	Strong Buy
Oct-30-19	Initiated	Cantor Fitzgerald	Overweight
Aug-19-19	Initiated	Evercore ISI	Outperform
Aug-19-19	Initiated	Goldman	Buy
Aug-19-19	Initiated	JP Morgan	Overweight
Aug-19-19	Initiated	Piper Jaffray	Overweight
Aug-19-19	Initiated	SVB Leerink	Outperform
Aug-19-19	Initiated	SunTrust	Buy
Aug-19-19	Initiated	William Blair	Outperform

View All

Health Catalyst Inc Stock (HCAT) Latest News

Nov 26, 2024

192,616 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Acquired by Millrace Asset Group Inc. - MarketBeat

Nov 26, 2024

Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Piper Sandler - MarketBeat

Nov 26, 2024

Nov 25, 2024

Piper Sandler raises Health Catalyst target to $12 on growth outlook - Investing.com

Nov 25, 2024

GSA Capital Partners LLP Decreases Holdings in Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat

Nov 25, 2024

Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 25, 2024

Nov 23, 2024

Trend Tracker for (HCAT) - Stock Traders Daily

Nov 23, 2024

Nov 21, 2024

Health Catalyst (STU:2YP) Earnings Yield (Joel Greenblatt) % : -14.33% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Health Catalyst Launches AI-Enabled Cyber Protection Product for Healthcare - WV News

Nov 20, 2024

Nov 19, 2024

Insider Sale: Chief People Officer Linda Llewelyn Sells Shares o - GuruFocus.com

Nov 19, 2024

Health Catalyst to Participate in Upcoming Investor Conferences - The Manila Times

Nov 19, 2024

Health Catalyst Leadership to Present at Three Major Healthcare Conferences in December | HCAT Stock News - StockTitan

Nov 19, 2024

Nov 18, 2024

Health Catalyst's chief people officer sells $11,602 in stock By Investing.com - Investing.com Canada

Nov 18, 2024

Health Catalyst's chief people officer sells $11,602 in stock - Investing.com

Nov 18, 2024

Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Update - MarketBeat

Nov 18, 2024

Nov 17, 2024

Janney Montgomery Scott LLC Buys Shares of 110,240 Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat

Nov 17, 2024

Nov 15, 2024

First Light Asset Management's Strategic Acquisition of Health C - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Health Catalyst (NASDAQ:HCAT) Given New $9.00 Price Target at Stephens - MarketBeat

Nov 14, 2024

Baillie Gifford & Co. Sells 308,742 Shares of Health Catalyst, Inc. (NASDAQ:HCAT) - MarketBeat

Nov 14, 2024

Nov 13, 2024

The Latest Analyst Ratings For Health Catalyst - Benzinga

Nov 13, 2024

Health Catalyst to Participate in Upcoming Investor Conference - The Manila Times

Nov 13, 2024

Health Catalyst (HCAT) Leadership to Present at Stephens Investment Conference 2024 | HCAT Stock News - StockTitan

Nov 13, 2024

Health Catalyst's SWOT analysis: stock poised for growth amid tech demand - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

When the Price of (HCAT) Talks, People Listen - Stock Traders Daily

Nov 12, 2024

Population Health Management Market to Grow by USD 22.55 Billion from 2024-2028, Driven by Rising Adoption of Healthcare IT, Report with AI Impact on TrendsTechnavio - The Malaysian Reserve

Nov 12, 2024

Nov 10, 2024

Health Catalyst (HCAT) Q3 Earnings Miss Estimates - MSN

Nov 10, 2024

Health Catalyst signs definitive agreement to acquire Intraprise Health - MSN

Nov 10, 2024

Nov 09, 2024

Health Catalyst (NASDAQ:HCAT) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nov 09, 2024

Health Catalyst Third Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St

Nov 09, 2024

One Health Catalyst Insider Raised Their Stake In The Previous Year - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Health Catalyst COO Daniel LeSueur sells $40,127 in stock - Investing.com India

Nov 08, 2024

Wellington Management Group LLP Increases Stake in Health Cataly - GuruFocus.com

Nov 08, 2024

Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Health Catalyst Reports Q3 Revenue Growth Amid Reduced Losses - TipRanks

Nov 08, 2024

Nov 07, 2024

Health Catalyst COO Daniel LeSueur sells $40,127 in stock By Investing.com - Investing.com Nigeria

Nov 07, 2024